Similar articles

• Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.

  Sternberg CN, Skoneczna I, Kerst JM, Albers P, Fossa SD, Agerbaek M, Dumez H, de Santis M, Théodore C, Leahy MG, Chester JD, Verbaeys A, Daugaard G, Wood L, Witjes JA, de Wit R, Geoffrois L, Sengelov L, Thalmann G, Charpentier D, Rolland F, Mignot L, Sundar S, Symonds P, Graham J, Joly F, Marreaud S, Collette L, Sylvester R; European Organisation for Research and Treatment of Cancer Genito-Urinary Cancers Group; Groupe d'Etude des Tumeurs Urogénitales; National Cancer Research Institute Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; German Association of Urologic Oncology. Sternberg CN, et al. Lancet Oncol. 2015 Jan;16(1):76-86. doi: 10.1016/S1470-2045(14)71160-X. Epub 2014 Dec 11. Lancet Oncol. 2015. PMID: 25498218 Clinical Trial.
• Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study.

  Koga F, Kihara K, Fujii Y, Yoshida S, Saito K, Masuda H, Kageyama Y, Kawakami S. Koga F, et al. BJU Int. 2009 Jul;104(2):189-94. doi: 10.1111/j.1464-410X.2008.08297.x. Epub 2008 Dec 22. BJU Int. 2009. PMID: 19154452
• Cost-effectiveness analysis of immediate radical cystectomy versus intravesical Bacillus Calmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer.

  Kulkarni GS, Alibhai SM, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Bayoumi AM. Kulkarni GS, et al. Cancer. 2009 Dec 1;115(23):5450-9. doi: 10.1002/cncr.24634. Cancer. 2009. PMID: 19685529
• Timing cystectomy and perioperative chemotherapy in the treatment of muscle invasive bladder cancer.

  Izawa JI, Chin JL, Winquist E. Izawa JI, et al. Can J Urol. 2006 Jun;13 Suppl 3:48-53. Can J Urol. 2006. PMID: 16818012 Review.
• High-Risk Nonmuscle Invasive Bladder Cancer: Selecting the Appropriate Patient for Timely Cystectomy.

  Koch GE, Luckenbaugh AN, Chang SS. Koch GE, et al. Urology. 2021 Jan;147:7-13. doi: 10.1016/j.urology.2020.05.023. Epub 2020 May 20. Urology. 2021. PMID: 32445767 Review.